Sort
40,608 grants matching “prostate cancer”
CANCER CENTER SUPPORT GRANT
$705,954Wayne State University · P30 · FY2002 · CA
Health Disparities and CVD: Admixture Mapping in the Jackson Heart Study
$705,882James Graham Wilson · University Of Mississippi Med Ctr · R01 · FY2009 · HL
Georgia CaRes
$705,799Sharad A. Ghamande · Augusta University · UG1 · FY2017 · CA
Community Outreach and Engagement (COE)
$705,778Roshan Bastani · University Of California Los Angeles · P30 · FY2025 · CA
Enhancing ARIC Infrastructure to Yield a New Cancer Epidemiology Cohort
$705,735Elizabeth A. Platz · Johns Hopkins University · U01 · FY2015 · CA
Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study
$705,569Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2024 · CA
Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer
$705,297Semanti Mukherjee · Sloan-Kettering Inst Can Research · R37 · FY2023 · CA
Southeast Michigan Community Network Program
$705,220Terrance L. Albrecht · Wayne State University · U54 · FY2013 · CA
Transgenic Core Facility
$705,137Deborah Swing · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Minority Based Community Clinical Oncology Program
$705,000David J Peace · University Of Illinois At Chicago · U10 · FY2007 · CA
Macrocycle inhibition of beta-catenin mediated transcription in prostate cancer
$704,918Susan K. Logan · New York University School Of Medicine · R01 · FY2024 · CA
Family RESPOND: Defining the Genetic Basis of Prostate Cancer Risk in African American Families
$704,882Christopher Alan Haiman · University Of Southern California · R01 · FY2025 · CA
Quantitative MRI to automatically delineate intraprostatic tumor for radiation therapy
$704,563Kun Qing · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Characterizing the theranostic potential of DLL3-targeting agents in high-grade neuroendocrine carcinomas of the lung and prostate
$704,422Lisa Bodei · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
New Instrumentation and Techniques for Hyperpolarized Metabolic and Perfusion MRI
$704,365Daniel B Vigneron · University Of California, San Francisco · R01 · FY2013 · EB
Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States
$704,354Xuehong Zhang · Brigham And Women'S Hospital · U01 · FY2023 · CA
ROLE OF PEPC, A CIRCULAR RNA ENCODED PROTEIN, IN CASTRATION-RESISTANT PROSTATE CANCER
$704,321Regents Of The University Of Minnesota · · FY2017 · Department of the Army
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis
$704,248David J Beebe · University Of Wisconsin-Madison · R01 · FY2016 · CA
Biological Studies
$704,174Brian E Henderson · University Of Southern California · U19 · FY2013 · CA
Exploring PSMA Biology in Tumor neovasculature
$704,122Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2018 · CA
A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T cells Targeting TAG72 in Patients with Recurrent Epithelial Ovarian Cancer
$704,036Lorna Rodriguez-Rodriguez · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
COMBINING CAR T CELLS WITH BLOCKADE OF TUMOR- INDUCED IMMUNOSUPPRESSION TO TARGET METASTATIC PROSTATE CANCER
$704,000University Of Southern California · · FY2021 · Defense Health Agency
Cancer Center Support Grant (Comprehensive)
$704,000Lawrence Corey · Fred Hutchinson Cancer Research Center · P30 · FY2011 · CA
ERADICATING METASTATIC PROSTATE CANCER THROUGH THE SYSTEMATIC IDENTIFICATION OF SYNERGISTIC DRUG COMBINATIONS
$703,705The Johns Hopkins University · · FY2018 · Department of the Army
A Systems Biology Approach to the Development of Cancer Biomarkers
$703,683Arul M Chinnaiyan · University Of Michigan At Ann Arbor · U01 · FY2010 · CA